Psychosocial aspects of cancer genetics: Women at high risk for breast and ovarian cancer

Seminars in Surgical Oncology

Volumn 18, Issue 4, 2000, Pages 333-338

  Kash, Kathryn M ^a,d   Ortega Verdejo, Karina ^a   Dabney, Mary Kay ^a   Holland, Jimmie C ^b   Miller, Daniel G ^c   Osborne, Michael P ^c  

^a BETH ISRAEL MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c STRANG CANCER PREVENTION CENTER   (United States)

^d Beth Israel Cancer Center   (United States)

Author keywords

Anxiety; BRCA1 genes; Breast neoplasms diagnosis genetics psychology prevention and control surgery; Decision making; Depression; Genetic counseling; Genetic predisposition to disease; Genetic screening; Incidence; Mammography utilization psychology; Mastectomy; Neoplasms psychology; Oral contraceptives; Ovarian neoplasms diagnosis genetics psychology prevention and control surgery; Ovariectomy; Patient compliance; Patient satisfaction; Psychological stress; Registries; Tamoxifen

Indexed keywords

ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER PREVENTION; CANCER RISK; DECISION MAKING; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; SOCIAL PSYCHOLOGY;

BREAST NEOPLASMS; DECISION MAKING; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; OVARIAN NEOPLASMS; PATIENT EDUCATION; STRESS, PSYCHOLOGICAL;

EID: 0034077067     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(200006)18:4<333::AID-SSU8>3.0.CO;2-4     Document Type: Article

References (38)

1. Hall JM, Lee MK, Newman B, et al: Linkage analysis of early-onset familial breast cancer to chromosome 17q21. Science 1990;250(4988): 1684-1689.
2. Lynch HT, Harries RE, Guirgis HA, et al: Familial association of breast/ovarian cancer. Cancer 1978;41:1543-1549.
3. Miki Y, Swensen J, Shattuck-Eidens D, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266(5182):66-71.
4. Wooster R, Bignell G, Lancaster J, et al: Identification of the breast cancer susceptibility gene BRCA2 [published erratum appears in Nature 1996;379(6567):749]. Nature 1995;378(6559):789-792.
5. Greenlee RT, Murray T, Bolden S, Wingo PA: Cancer statistics, 2000. CA Cancer J Clin 2000;50:7-33.
6. Tibben A, Duivenvoorden HJ, Vegter-van der Vlis M, et al: Presymptomatic DNA testing for Huntington disease: identifying the need for psychological intervention. Am J Med Genet 1993;48:137-144.
7. Wiggins S, Whyte P, Huggins M, et al: The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing. N Engl J Med 1992;327:1401-1405.
8. Croyle RT, Smith KR, Botkin JR, et al: Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychol 1997;16:63-72.
9. Lerman C, Narod S, Schulman K, et al: BRCA1 testing in hereditary breast-ovarian cancer: a prospective study of patient decision making and outcomes. JAMA 1996;275:1885-1892.
10. Lerman C, Hughes C, Lemon SJ, et al: What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing. J Clin Oncol 1998;16:1650-1654.
11. Prochaska JO, DiClemente CC, Norcross JC: In search of how people change. Applications to addictive behaviors. Am Psychol 1992;47: 1102-1114.
12. Rosenstock IM, Strecher VJ, Becker MH: Social learning theory and the Health Belief Model. Health Educ Q 1988;15:175-183.
13. Redelmeier DA, Rozin P, Kahneman D: Understanding patients' decisions. Cognitive and emotional perspectives [Review]. JAMA 1993;270:72-76.
14. Claus EB, Risch NJ, Thompson WD: Age of onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1992;131:961-972.
15. Lerman C, Daly M, Sands C, et al: Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 1993;85:1074-1080.
16. Kash KM: Psychological distress associated with genetic breast cancer risk. In Eeles RA, Ponder BA, Easton DF (eds): "Genetic predisposition to cancer." London: Chapman & Hall; 1996; p. 282-289.
17. Kash KM, Holland JC, Halper MS, Miller DG: Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 1992;84:24-30.
18. Burke W, Daly M, Garber J, et al: Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Study Genetics Consortium [Review]. JAMA 1997;277:997-1003.
19. Fisher B, Constantino JP, Wickerham DL, et al: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-I Study. J Natl Cancer Inst 1998;90: 1371-1388.
20. Pennisi VR, Capozzi A, Perez FM: Subcutaneous mastectomy data: a preliminary report. Plast Reconstr Surg 1977;59:53-56.
21. Pennisi VR, Capozzi A: Subcutaneous mastectomy data: a final statistical analysis of 1500 patients. Aesthetic Plast Surg 1989; 13:15-21.
22. Goodnight JE Jr, Quagliana JM, Morton DL: Failure of subcutaneous mastectomy to prevent the development of breast cancer. J Surg Oncol 1984;26:198-201.
23. Mies C: Recurrent secretory carcinoma in residual mammary tissue after mastectomy. Am J Surg Pathol 1993;17:715-721.
24. Hartmann LC, Schaid DJ, Woods JE, et al: Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 1999;340:77-84.
25. Rebbeck TR, Levin AM, Eisen A, et al: Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 1999;91:1475-1479.
26. Stefanek ME: Bilateral prophylactic mastectomy: issues and concerns [Review]. Monogr Natl Cancer Inst 1995;17:37-42.
27. Borgen PI, Hill AD, Tran KN, et al: Patient regrets after bilateral prophylactic mastectomy. Ann Surg Oncol 1998;5:603-606.
28. Hoskins WJ: Prospective on ovarian cancer: why prevent? J Cell Biochem Suppl 1995;23:189-199.
29. Narod SA, Risch H, Moslehi R, et al: Oral contraceptives and the risk of hereditary ovarian cancer. N Engl J Med 1998;339:424-428.
30. Tobacman JK, Greene MH, Tucker MA, et al: Intra-abdominal carcinomatosis after prophylactic cophorectomy in ovarian-cancer-prone families. Lancet 1982;2(8302):795-597.
31. NIH Consensus Conference. Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer. JAMA 1995;273:491-497.
32. Piver MS, Jishi MF, Tsukada Y, et al: Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry. Cancer 1993;71:2751-2755.
33. Green J, Murton F, Statham H: Psychosocial issues raised by a familial ovarian cancer registry. J Med Genet 1993;30:575-579.
34. th annual meeting program and abstracts; 1995 March 8-11; Houston, Texas. Paper session on Behaviour Science and Quality of Life; 1995 March 9; Madison (WI): ASPO; 1995.
35. Wardle FJ, Collins W, Pernet AL, et al: Psychological impact of screening for familial ovarian cancer. J Natl Cancer Inst 1993;85: 653-657.
36. Schwartz MD, Lerman C, Miller SM, et al: Coping disposition, perceived risk, and psychological distress among women at increased risk for ovarian cancer. Health Psychol 1995;14:232-235.
37. Erlick Robinson G, Rosen BP, Bradley LN, et al: Psychological impact of screening for familial ovarian cancer: reactions to initial assessment. Gynecol Oncol 1997;65:197-205.
38. Schwartz M, Lerman C, Daly M, et al: Utilization of ovarian cancer screening by women at increased risk. Cancer Epidemiol Biomarkers Prev 1995;4:267-273.